Year archive

Nanjing Leads Biolabs Co., Ltd. — 2025 filings

All 58 regulatory filings released by Nanjing Leads Biolabs Co., Ltd. (9887) in 2025, sourced directly from the official regulator.

58 Filings

2025 Period

2025 filings (58)

Filing	Released	Lang
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-12-31	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-12-31	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE OF THE BOARD OF DIRECTORS Remuneration Information	2025-12-31	English
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE IB/II TRIAL FOR PLATINUM-RESISTANT OVARIAN CANCER Regulatory Filings	2025-12-23	English
VOLUNTARY ANNOUNCEMENT - LBL-047 DOSED FIRST SUBJECT IN PHASE I TRIAL Regulatory Filings	2025-12-23	English
ARTICLES OF ASSOCIATION Governance Information	2025-12-17	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 17, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-12-17	English
INSIDE INFORMATION - PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION PROGRAM BY THE COMPANY Share Issue/Capital Change	2025-12-15	English
VOLUNTARY ANNOUNCEMENT - LBL-034 CLINICAL DATA PRESENTED AT THE 67TH ASH ANNUAL MEETING Regulatory Filings	2025-12-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-02	English
VOLUNTARY ANNOUNCEMENT - LBL-047 RECEIVED IND APPROVAL FROM NMPA Regulatory Filings	2025-12-01	English
The H Share Award Scheme Regulatory Filings	2025-11-28	English
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, DECEMBER 17, 2025 Proxy Solicitation & Information Statement	2025-11-28	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-28	English
(1) PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME; (2) PROPOSED AUTHORIZATION TO THE BOARD OF DIRECTORS AND/OR THE DELEGATEE TO HANDLE MATTERS RELATING TO THE H SHARE AWARD SCHEME; (3) Proxy Solicitation & Information Statement	2025-11-28	English
ANNOUNCEMENT BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING AGM Information	2025-11-27	English
(1) PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME; AND (2) PROPOSED CANCELLATION OF THE SUPERVISORY COMMITTEE AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Regulatory Filings	2025-11-25	English
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE II TRIAL OF FIRST-LINE TREATMENT FOR HEPATOCELLULAR CARCINOMA Regulatory Filings	2025-11-10	English
VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE MSCI GLOBAL SMALL CAP INDEXES Regulatory Filings	2025-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-04	English
VOLUNTARY ANNOUNCEMENT - FURTHER ANNOUNCEMENT ON RESEARCH ABSTRACTS ACCEPTED FOR PRESENTATION AT THE 67TH ASH ANNUAL MEETING Regulatory Filings	2025-11-03	English
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN PHASE II TRIAL OF FIRST-LINE TREATMENT FOR BILIARY TRACT CANCER Regulatory Filings	2025-10-27	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2025-10-17	English
(REVISED) INSIDE INFORMATION - EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH DIANTHUS FOR LBL-047 Regulatory Filings	2025-10-16	English
INSIDE INFORMATION - EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH DIANTHUS FOR LBL-047 Regulatory Filings	2025-10-16	English
VOLUNTARY ANNOUNCEMENT RESEARCH RESULTS OF TWO INNOVATIVE DRUGS TO BE PRESENTED AT THE 67TH ASH ANNUAL MEETING Regulatory Filings	2025-10-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-26	English
VOLUNTARY ANNOUNCEMENT-LBL-047 RECEIVED IND APPROVAL FROM THE U.S. FDA Regulatory Filings	2025-09-22	English
ARTICLES OF ASSOCIATION Governance Information	2025-09-17	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION Governance Information	2025-09-17	English
VOLUNTARY ANNOUNCEMENT - LBL-024 DOSED FIRST PATIENT IN MELANOMA PHASE IB/II TRIAL OF OPAMTISTOMIG Regulatory Filings	2025-09-12	English
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-09-08	English
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-09-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Share Issue/Capital Change	2025-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-29	English
VOLUNTARY ANNOUNCEMENT - LBL-034 DOSED FIRST PATIENT IN PHASE II TRIAL Regulatory Filings	2025-08-25	English
STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Share Issue/Capital Change	2025-08-21	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-19	English
Next Day Disclosure Return Share Issue/Capital Change	2025-08-11	English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION Share Issue/Capital Change	2025-08-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-04	English
CHANGE IN COMPOSITION OF NOMINATION COMMITTEE AND APPOINTMENT OF LEAD INED Board/Management Information	2025-07-25	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-07-25	English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Share Issue/Capital Change	2025-07-24	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-07-24	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-07-24	English
List of Directors and their Roles and Functions Governance Information	2025-07-24	English
ARTICLES OF ASSOCIATION Governance Information	2025-07-24	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-07-24	English
Documents on Display Regulatory Filings	2025-07-17	English
GLOBAL OFFERING Share Issue/Capital Change	2025-07-17	English
GLOBAL OFFERING Capital/Financing Update	2025-07-17	English
PHIP (1st submission) Share Issue/Capital Change	2025-06-23	English
PHIP (1st submission) Audit Report / Information FY 2022	2025-06-23	English
OC Announcement - Appointment Regulatory Filings	2025-06-04	English
Application Proof (1st submission) Audit Report / Information FY 2024	2025-06-04	English
Application Proof (1st submission) Share Issue/Capital Change	2025-06-04	English